Why Some Alzheimer’s Drugs Work Better Than Others
UK DRINew research reveals why some Alzheimer’s drugs are more effective—lecanemab binds better to toxic proteins in early-stage disease, offering key insight.
All posts by UK DRI
The UK DRI breaks new ground by bringing together world-leading expertise in biomedical, care and translational dementia research in a national institute currently made up of over 600 researchers and a support team of over 50, all growing rapidly.
The institute carries out research relevant to all dementias, including Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, vascular dementia, Huntington’s disease and beyond.
UK DRI and Parkinson’s UK join forces
UK DRI & Parkinson’s UK launch a £10m research centre to find new treatments & a cure for Parkinson’s, uniting top scientists & cutting-edge resources.
“Healthy fats” could protect against motor neuron disease
New research findings from the UK Dementia Research institute suggest enhancing levels of “healthy fats” like omega-3s in the brain could be beneficial in MND
Sleep may not clear brain toxins as previously thought
Surprising new research from the UKDRI reveals that contrary to previous understanding, the brain’s ability to rid itself of toxins may be reduced during sleep
New non-invasive deep brain stimulation
UK Dementia Research Institute shares news of a new form of non-invasive deep brain stimulation that could provide alternative treatment for brain diseases.
Making it Brain – Finding a Career in Neuroscience
Brilliant Neuroscience research & career webinars from the UK Dementia Research Institute aimed at for young people and students
Enabling dementia research using UK Biobank
Talks from a special webinar hosted by the UK Dementia Research Institute exploring opportunities to harness the UK Biobank’s data resources for your research.
Smart watches may detect Parkinson’s years before symptoms
New UK Dementia Research Institute Research suggests smart watches could identify Parkinson’s disease up to seven years before symptoms appear
The UK Dementia Research Institute has a new Director
Professor Siddharthan Chandran appointed to replace Professor Bart De Strooper as Director of the UK Dementia Research Institute.
Improving animal models for the study of Alzheimer’s
The UK DRI hosted a presentation from Dr Michael Sasner discussing recent advances in efforts to generate translationally-relevant mouse models of Alzheimer’s.
Building an ‘atlas’ of the Alzheimer’s brain
Hear about UK Dementia Research Institute work on ‘Building an ‘atlas’ of the Alzheimer’s brain’ with Dr Johanna Jackson
A Clinical & Scientific perspective on Lecanemab – UKDRI
Catch-up on the UKDRI Roundtable to discuss the promising Phase III trial data of lecanemab ollowing presentation of results from Eisai/Biogen at CTAD.
- 1
- 2